<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Dihydropyrimidine Dehydrogenase Deficiency and the Use of Fluoropyrimidine Chemotherapy Drugs; Establishment of a Public Docket; Request for Comments</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Dihydropyrimidine Dehydrogenase Deficiency and the Use of Fluoropyrimidine Chemotherapy Drugs; Establishment of a Public Docket; Request for Comments</h1>
    <p class="timestamp">Published: 2025-05-20 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the establishment of a docket to solicit public comment for information on dihydropyrimidine dehydrogenase (DPD) deficiency and the use of fluorouracil and capecitabine (both fluoropyrimidine chemotherapy drugs). The purposes of the docket establishment are to foster Agency transparency and to solicit input on the currently available information on DPD deficiency and the use of fluorouracil and capecitabine.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2025-08960</p>
    <p><strong>Publication Date:</strong> 2025-05-20</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2025/05/20/2025-08960/dihydropyrimidine-dehydrogenase-deficiency-and-the-use-of-fluoropyrimidine-chemotherapy-drugs">https://www.federalregister.gov/documents/2025/05/20/2025-08960/dihydropyrimidine-dehydrogenase-deficiency-and-the-use-of-fluoropyrimidine-chemotherapy-drugs</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2025-08960</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
